Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

BUY
$0.22 - $0.56 $18,684 - $47,559
84,928 Added 97.88%
171,695 $38.1 Million
Q1 2023

May 11, 2023

BUY
$0.56 - $1.15 $22,400 - $46,000
40,000 Added 85.53%
86,767 $53.8 Million
Q3 2022

Nov 14, 2022

BUY
$0.43 - $4.31 $4,889 - $49,004
11,370 Added 32.12%
46,767 $108 Million
Q2 2022

Aug 08, 2022

BUY
$2.81 - $12.91 $64,236 - $295,122
22,860 Added 182.34%
35,397 $120,000
Q1 2022

May 13, 2022

BUY
$3.81 - $9.79 $47,765 - $122,737
12,537 New
12,537 $109,000

Others Institutions Holding CELU

About Celularity Inc


  • Ticker CELU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,424,000
  • Market Cap $319M
  • Description
  • Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...
More about CELU
Track This Portfolio

Track Ipg Investment Advisors LLC Portfolio

Follow Ipg Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ipg Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ipg Investment Advisors LLC with notifications on news.